Font Size: a A A
Keyword [Dual Antiplatelet Therapy]
Result: 1 - 20 | Page: 1 of 5
1. Coronary Artery Bypass Graft Clinical Study Of Dual-antiplatelet Therapy
2. Chinese Herbal Medicine Naoxintong Capsule Combined With Dual Antiplatelet Therapy In A Rat Model Of Coronary Microembolization Induced By Homologous Microthrombi
3. Adherence With Dual Antiplatelet Therapy And Its Influence On Clinical Outcomes In Patients After Undergoing Percutaneous Coronary Stenting For 1 Year
4. Effects Of Omeprazole And Pantoprazole On The Antiplatele Efficacy Of Clopidogrel
5. Long-term Follow-up Of Dual Antiplatelet Therapy With Aspirin And Low-dose Clopidogrel In Patients Undergoing Percutaneous Coronary Intervention
6. Optimal Dual Antiplatelet Therapy After Percutaneous Coronary Intervention
7. Effects Of Different Doses Of Naoxintong Capsule Combined With Dual Antiplatelet Therapy In Patients With Cytochrome P4502C19*2Gene Mutation After Percutaneous Coronary Intervention
8. The Optimal Duration Of Dual Antiplatelet Therapy In Patients Undergoing Percutaneous Coronary Intervention: A Meta-analysis
9. Association Of PON1Genetic And Epigenetic Variation With The Clinical Efficacy Of Dual-antiplatelet Therapy
10. Research On High On-treatment Platelet Reactivity And CYP2C19Polymorphisms Up To Six Months After Percutaneous Coronary Interventions
11. Safety And Efficacy Of Short Term Versus Long Term Dual Anti-platelet Therapy After Second Generation Drug Eluting Stent Therapy: A Meta-analysis
12. Comparative Study Of The Withdrawal Time About Dual Antiplatelet Therapy Between Permanent Polymer-coating Stent And Polymer-free Stent
13. Efficacy And Safety Of Long-term Use Of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention In Elderly Patients
14. Curative Effect Observation And Security Research About Short-term Dual Antiplatelet Therapy With Transient Ischemic Attack And Prediction
15. Effects And Cost-effectiveness Analysis Of Naoxintong Capsule Combined With Dual Antiplatelet Therapy In Patients With CYP2C19 Loss-of-function Gene Mutant After Percutaneous Coronary Intervention
16. Optimal Duration Of Dual Antiplatelet Therapy In Patients With Acute Coronary Syndromes Undergoing Drug-eluting Stent Implantation: A Meta-analysis
17. Different Duration Of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention With Drug-eluting Stents In Coronary Disease: A Systematic Review
18. Evaluation Of Antithrombotic Therapies After Pci In Patients With An Indication For Chromnic Oral Anticoagulation:a Meta-Analysis
19. The Efficacy Of Intensive Lipid-lowering Combined With Dual Antiplatelet Therapy In Acute Cerebral Infarction Patients As Well As Its Effects On Blood Lipid And Hypersensitive C-reactive Protein (CRP)
20. Efficacy And Safety Of Short-term (≤6 Months) Duration Of Dual Antiplatelet Therapy After Second Generation Drug Eluting Stents:a Meta-Analysis Of Randomized Controlled Trials
  <<First  <Prev  Next>  Last>>  Jump to